Point State Capital LP Eli Lilly & CO Put Options Transaction History

Point State Capital LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $3.52 Million - $4.37 Million	-15,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $5.89 Million - $7.31 Million	-26,200 Reduced 63.59%	15,000 $4.14 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $6.02 Million - $6.97 Million	41,200 New	41,200 $6.1 Million

4,009

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.